Quarterly Transactions Made in Corvus Pharmaceuticals, Inc. (CRVS)
This table provides information about the institutional ownership of Corvus Pharmaceuticals, Inc. (CRVS). The information is specifically focused on institutions that hold shares of Corvus Pharmaceuticals, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 1,411,556 | 9,758,681 | 11,170,237 | 6,061,094 | 495,616 | 6,556,710 | 4,613,527 | |
| Q4 2021 | 5,098,198 | 1,516,292 | 6,614,490 | 4,414,759 | 2,556,513 | 6,971,272 | -356,782 | |
| Q1 2022 | 1,946,285 | 123,525 | 2,069,810 | 1,426,837 | 940,317 | 2,367,154 | -297,344 | |
| Q2 2022 | 1,012,034 | 53,147 | 1,065,181 | 446,966 | 1,894,186 | 2,341,152 | -1,275,971 | |
| Q3 2022 | 423,334 | 72,169 | 495,503 | 726,534 | 0 | 726,534 | -231,031 | |
| Q4 2022 | 49,948 | 588,524 | 638,472 | 1,248,840 | 0 | 1,248,840 | -610,368 | |
| Q1 2023 | 167,815 | 35,354 | 203,169 | 337,861 | 0 | 337,861 | -134,692 | |
| Q2 2023 | 518,932 | 3,183,161 | 3,702,093 | 2,292,277 | 0 | 2,292,277 | 1,409,816 | |
| Q3 2023 | 810,561 | 161,467 | 972,028 | 388,321 | 0 | 388,321 | 583,707 | |
| Q4 2023 | 547,637 | 94,914 | 642,551 | 326,417 | 0 | 326,417 | 316,134 | |
| Q1 2024 | 390,054 | 48,457 | 438,511 | 1,662,179 | 0 | 1,662,179 | -1,223,668 | |
| Q2 2024 | 4,480,412 | 6,142,457 | 10,622,869 | 435,497 | 0 | 435,497 | 10,187,372 | |
| Q3 2024 | 1,724,302 | 3,237,757 | 4,962,059 | 2,525,384 | 0 | 2,525,384 | 2,436,675 | |